Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aymone Gurtner

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Experimental & Clinical Cancer Research : CR|April 22, 2022
Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancerLivia Ronchetti, Irene Terrenato, Margherita Ferretti, et al.
Cell Death & Disease|December 13, 2023
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, et al.
Oncotarget|October 30, 2016
The laminA/NF-Y protein complex reveals an unknown transcriptional mechanism on cell proliferationLucia Cicchillitti, Isabella Manni, Carmine Mancone, et al.
Cancers|September 13, 2025
Dysregulated MicroRNAs in Urinary Non-Muscle-Invasive Bladder Cancer: From Molecular Characterization to Clinical ApplicabilityNouha Setti Boubaker, Aymone Gurtner, Sami Boussetta, et al.
Experimental Hematology & Oncology|February 18, 2025
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Francesca De Paolis, Domenico Alessandro Silvestris, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2008
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatmentClaudia Colussi, Chiara Mozzetta, Aymone Gurtner, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Experimental & Clinical Cancer Research : CR|April 22, 2022
Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancerLivia Ronchetti, Irene Terrenato, Margherita Ferretti, et al.
Cell Death & Disease|December 13, 2023
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, et al.
Oncotarget|October 30, 2016
The laminA/NF-Y protein complex reveals an unknown transcriptional mechanism on cell proliferationLucia Cicchillitti, Isabella Manni, Carmine Mancone, et al.
Cancers|September 13, 2025
Dysregulated MicroRNAs in Urinary Non-Muscle-Invasive Bladder Cancer: From Molecular Characterization to Clinical ApplicabilityNouha Setti Boubaker, Aymone Gurtner, Sami Boussetta, et al.
Experimental Hematology & Oncology|February 18, 2025
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Francesca De Paolis, Domenico Alessandro Silvestris, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2008
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatmentClaudia Colussi, Chiara Mozzetta, Aymone Gurtner, et al.
Pageof 4